Clinical Efficacy of Oral L-carnitine Supplementation in Chronic Peritoneal Dialysis Patients
碩士 === 國立成功大學 === 臨床藥學研究所 === 92 === Uremic patients receiving chronic peritoneal dialysis (PD), similar to hemodialysis patients, were associated with a reduction in plasma and tissue free carnitine concentration and high ratio of acyl-carnitine to free carnitine (AC/FC). The disturbed L-carnitin...
Main Authors: | Shih-Ju Hsiao, 蕭詩如 |
---|---|
Other Authors: | Jeng-Jong Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/05765339348794535108 |
Similar Items
-
Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis
by: Masako Kuwasawa-Iwasaki, et al.
Published: (2020-11-01) -
Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis
by: Satoshi Shimizu, et al.
Published: (2019-11-01) -
Effect of telmisartan in combined with L-carnitine on peritoneal dialysis patients
by: Effect of telmisartan in combined with L-carnitine on peritoneal dialysis patients, et al.
Published: (2016-07-01) -
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
by: Carmela Rago, et al.
Published: (2021-02-01) -
Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients
by: Afsoon Emami Naini, et al.
Published: (2012-01-01)